Why Britt's Huntington's on General Hospital and Victor's transplanted heart on Young and Restless don't work as well as fake ...
When weird fungal epidemics crop up in far-flung places, scientists work together to unravel how the microscopic murderers ...
The doctor, Salvador Plasencia, had asked “I wonder how much this moron will pay” before supplying the drug to Mr. Perry, who ...
Tiny repeated stretches of DNA in your genome may quietly shape how your body works, how your brain develops and how you ...
The results of recent clinical trials of gene therapy uniQure in the USA and the UK, and detailed in a uniQure media release, ...
The successful gene therapy is AMT-130, developed by a company called UniQure. In a three-year trial of 29 participants with ...
The biological world is always expanding as research is constantly being done. Because of this, many findings often fall ...
H5N1 bird flu has been circulating in U.S. wildlife since late 2021 but has caused only one human fatality. Now a different ...
Six people have died of leptospirosis, a rare bacterial illness often found in contaminated water. The storm increased the ...
A new, one-time treatment could be the answer to cure Huntington's disease, a neurodegenerative disease long-considered untreatable. Although results are promising, approval for the treatment is ...
US regulators laid out new guidelines for approving custom-made treatments for individual patients, a move that could bring the promise of gene editing to more people with devastating diseases. Food ...
UniQure stock is rated a Buy with a $66 price target, offering upside after recent FDA pushback on AMT-130 Huntington's therapy trial design. AMT-130 is the first disease-modifying therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback